<?xml version="1.0" encoding="UTF-8"?>
<search_results count="2531">
  <query>COVID-19</query>
  <!-- Additional study fields may be added over time -->
  <study rank="1">
    <title>Duvelisib to Combat COVID-19</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Duvelisib</intervention>
      <intervention type="Procedure">Peripheral blood draw</intervention>
    </interventions>
    <locations>
      <location>Washington University School of Medicine, Saint Louis, Missouri, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04372602</url>
  </study>
  <study rank="2">
    <title>Observational Cohort of COVID-19 Patients at Raymond-Poincare</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions/>
    <locations>
      <location>Department of Infectiology, Raymond Poincaré Hospital, APHP, Garches, France</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04364698</url>
  </study>
  <study rank="3">
    <title>COVID-19 Surveillance Based on Smart Wearable Device</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions/>
    <locations>
      <location>Peking University First Hospital, Beijing, Beijing, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04459637</url>
  </study>
  <study rank="4">
    <title>A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Infliximab</intervention>
    </interventions>
    <locations>
      <location>Tufts Medical Center, Boston, Massachusetts, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04425538</url>
  </study>
  <study rank="5">
    <title>Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Tramadol</intervention>
      <intervention type="Other">Standard care delivered in the isolation hospitals.</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04454307</url>
  </study>
  <study rank="6">
    <title>Safety and Efficacy of C21 in Subjects With COVID-19</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">C21</intervention>
      <intervention type="Drug">Placebo</intervention>
    </interventions>
    <locations>
      <location>Department of Medicine, Civil Hospital and B J Medical College, Ahmadabad, Gujarat, India</location>
      <location>Department of Medicine, Noble Hospitals Pvt. Ltd, Pune, Maharashtra, India</location>
      <location>Respiratory Medicine, University College Hospital, London, United Kingdom</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04452435</url>
  </study>
  <study rank="7">
    <title>Application of Desferal to Treat COVID-19</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Deferoxamine</intervention>
    </interventions>
    <locations>
      <location>Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04333550</url>
  </study>
  <study rank="8">
    <title>Dornase Alpha for the Treatment of COVID-19</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Pulmozyme</intervention>
    </interventions>
    <locations>
      <location>Acıbadem Altunizade Hospital, Istanbul, Turkey</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04432987</url>
  </study>
  <study rank="9">
    <title>Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19</title>
    <status open="N">Active, not recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Favipiravir</intervention>
      <intervention type="Other">Placebo</intervention>
    </interventions>
    <locations>
      <location>Asst Fatebenefratelli Sacco, Milano, Italy</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04336904</url>
  </study>
  <study rank="10">
    <title>Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Tocilizumab</intervention>
    </interventions>
    <locations>
      <location>Hospital Universitario de Cabueñes, Gijón, Asturias, Spain</location>
      <location>Hospital Universitario Central Asturias, Oviedo, Asturias, Spain</location>
      <location>Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain</location>
      <location>Hospital Sant Joan de Déu de Manresa, Manresa, Barcelona, Spain</location>
      <location>Hospital de Mataró, Mataró, Barcelona, Spain</location>
      <location>Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain</location>
      <location>Hospital Universitario Marqués Valdecilla, Santander, Cantabria, Spain</location>
      <location>Hospital Público General del Tomelloso, Tomelloso, Ciudad Real, Spain</location>
      <location>Hospital Jerez de la Frontera, Jerez De La Frontera, Cádiz, Spain</location>
      <location>Hospital Universitari Son Espases, Palma De Mallorca, Islas Baleares, Spain</location>
      <location>Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain</location>
      <location>Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain</location>
      <location>Hospital Universitario de Getafe, Getafe, Madrid, Spain</location>
      <location>Hospital Universitario de Getafe, Getafe, Madrid, Spain</location>
      <location>Hospital Rey Juan Carlos, Móstoles, Madrid, Spain</location>
      <location>Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain</location>
      <location>Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain</location>
      <location>Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain</location>
      <location>Hospital Nuestra Señora del Prado, Talavera De La Reina, Toledo, Spain</location>
      <location>Complejo Hospitalario Universitario de Albacete, Albacete, Spain</location>
      <location>Hospital Infanta Cristina, Badajoz, Spain</location>
      <location>Hospital Clínic i Provincial Barcelona, Barcelona, Spain</location>
      <location>Hospital de la Santa Creu i Sant Pau, Barcelona, Spain</location>
      <location>Hospital Universitario de Burgos, Burgos, Spain</location>
      <location>Hospital General Universitario de Ciudad Real, Ciudad Real, Spain</location>
      <location>Hospital San Pedro Alcántara, Cáceres, Spain</location>
      <location>Hospital Universitario Dr. Josep Trueta, Gerona, Spain</location>
      <location>Hospital Universitario Clínico San Cecilio, Granada, Spain</location>
      <location>Hospital Universitario Virgen de las Nieves, Granada, Spain</location>
      <location>Hospital General Universitario Gregorio Marañón, Madrid, Spain</location>
      <location>Hospital Universitario 12 de Octubre, Madrid, Spain</location>
      <location>Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain</location>
      <location>Hospital Universitario HM Sanchinarro, Madrid, Spain</location>
      <location>Hospital Universitario Infanta Leonor, Madrid, Spain</location>
      <location>Hospital Universitario Ramón y Cajal, Madrid, Spain</location>
      <location>Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain</location>
      <location>Hospital Regional Universitario de Málaga, Málaga, Spain</location>
      <location>Complexo Hospitalario Universitario de Ourense, Orense, Spain</location>
      <location>Hospital Universitario Salamanca, Salamanca, Spain</location>
      <location>Hospital Universitario Virgen de la Macarena, Sevilla, Spain</location>
      <location>Hospital Universitario Virgen del Rocío, Sevilla, Spain</location>
      <location>Hospital Virgen de la Salud, Toledo, Spain</location>
      <location>Hospital Clinico Universitario de Valencia, Valencia, Spain</location>
      <location>Hospital Universitari i Poliectenic La Fe, Valencia, Spain</location>
      <location>Hospital Universitario Dr. Peset, Valencia, Spain</location>
      <location>Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain</location>
      <location>Hospital Universitario Miguel Servet, Zaragoza, Spain</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04445272</url>
  </study>
</search_results>
